Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Arthroscopic Lunate Fossa Resection Arthroplasty for Kienbock’S Disease Publisher Pubmed



Kamrani RS1 ; Najafi E1 ; Azizi H2 ; Banihashemian M3 ; Saremi H4 ; Farhoud AR5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Orthopaedic and Trauma Surgery, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Occupational Therapy, School of Rehabilitation, University of Social Welfare and Rehabilitation Sciences (USER), Tehran, Iran
  3. 3. Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  4. 4. Department of Orthopedics, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  5. 5. Department of Orthopedics, Joint Reconstruction Research Center, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Hand Surgery: European Volume Published:2023


Abstract

The aim of this study was to assess the outcome of arthroscopic lunate fossa resection arthroplasty for patients with Kienbock’s disease, previously managed without operation, and a non-functional lunate fossa. For adult patients with relapse or exacerbation of pain from Kienbock’s disease 2 years after the onset of symptoms, arthroscopic removal of lunate fossa cartilage was performed to reach bleeding bone, if the cartilage in the lunate fossa was non-functional and the scaphoid fossa was intact. Sixteen patients (mean age 35 years; range 27–56) were included. At a mean follow-up of 39 months (range 24–64), the preoperative mean visual analogue pain scale and QuickDASH score decreased from 7 (SD 2.2) and 50 (SD 16) to 1.4 (SD 1.6) and 13 (SD 9.6), respectively. A minor deterioration in mean radioscaphoid angle and carpal height ratio occurred. Arthroscopic lunate fossa resection arthroplasty is a viable option for selected patients with Kienbock’s disease. Level of evidence: IV. © The Author(s) 2023.